201 related articles for article (PubMed ID: 35287628)
1. Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.
Daetwyler E; Bargetzi M; Otth M; Scheinemann K
BMC Cancer; 2022 Mar; 22(1):267. PubMed ID: 35287628
[TBL] [Abstract][Full Text] [Related]
2. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
3. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE).
Clark RA; Mostoufi-Moab S; Yasui Y; Vu NK; Sklar CA; Motan T; Brooke RJ; Gibson TM; Oeffinger KC; Howell RM; Smith SA; Lu Z; Robison LL; Chemaitilly W; Hudson MM; Armstrong GT; Nathan PC; Yuan Y
Lancet Oncol; 2020 Mar; 21(3):436-445. PubMed ID: 32066539
[TBL] [Abstract][Full Text] [Related]
4. Late effects of high-dose methotrexate in childhood cancer survivors: a Swiss single centre observational study.
Brunold K; Otth M; Scheinemann K
Discov Oncol; 2024 Jan; 15(1):17. PubMed ID: 38270745
[TBL] [Abstract][Full Text] [Related]
5. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.
Chen C; Qin N; Wang M; Dong Q; Tithi SS; Hui Y; Chen W; Wu G; Kennetz D; Edmonson MN; Rusch MC; Thrasher A; Easton J; Mulder HL; Song N; Plonski NM; Shelton K; Im C; Ehrhardt MJ; Nichols KE; Leisenring WM; Stratton KL; Howell R; Yasui Y; Bhatia S; Armstrong GT; Ness KK; Hudson MM; Zhang J; Wang H; Srivastava DK; Robison LL; Wang Z
Lancet Oncol; 2023 Oct; 24(10):1147-1156. PubMed ID: 37797633
[TBL] [Abstract][Full Text] [Related]
6. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
8. Nutritional interventions for survivors of childhood cancer.
Cohen JE; Wakefield CE; Cohn RJ
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
[TBL] [Abstract][Full Text] [Related]
9. Impacts of physical late effects on presenteeism in childhood cancer survivors.
Soejima T; Sato I; Takita J; Koh K; Kaneko T; Inada H; Ozono S; Kamibeppu K
Pediatr Int; 2020 Nov; 62(11):1241-1249. PubMed ID: 32402092
[TBL] [Abstract][Full Text] [Related]
10. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
11. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Szőnyi LP; Levitt GA; Bardi E; Skinner R; van Dalen EC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD008205. PubMed ID: 30985922
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma.
Nakano T; Kobayashi R; Matsushima S; Hori D; Yanagi M; Suzuki D; Kobayashi K
Int J Hematol; 2021 May; 113(5):744-750. PubMed ID: 33389654
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia/lymphoma: a retrospective study.
Mandal P; Samaddar S; Chandra J; Parakh N; Goel M
Indian J Hematol Blood Transfus; 2020 Jul; 36(3):498-504. PubMed ID: 32647424
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Sasaki K; Takeda T; Utsumi J; Mimaya J; Ohta S; Ninomiya T; Takaue Y
Int J Hematol; 1991 Aug; 54(4):307-13. PubMed ID: 1777605
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy, side effects and blood concentration monitoring of high-dose methotrexate in treatment of 180 children with acute lymphoblastic leukemia].
Wang H; Chi ZF; Li S; Wang XL; Hao LC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):949-52. PubMed ID: 21867621
[TBL] [Abstract][Full Text] [Related]
17. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
[TBL] [Abstract][Full Text] [Related]
18. Solitary serum methotrexate level 36 hours post high-dose methotrexate: A safe, efficacious, and cost-effective strategy to monitor methotrexate toxicities in childhood leukemia in resource-limited centers.
Khera S; Kapoor R; Pramanik SK
Pediatr Blood Cancer; 2020 Jul; 67(7):e28387. PubMed ID: 32400952
[TBL] [Abstract][Full Text] [Related]
19. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK
Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
